Costs and Benefits of Unapproved Experimental Drugs

Vulnerable patients with multiple complications could utilize experimental drugs to improve quality of life. A benefit of the process is that it allows patients to avoid the time-consuming FDA approval process. The trials and testing processes reveal the thoroughness of the development framework and emphasis on patients’ safety (Mahant, 2020). Further, the voluntary aspect also allows patients to make independent decisions on using experimental drugs. However, it is necessary to complete the trial process to ascertain the advantages and disadvantages of experimental drugs. The goal is to eliminate concerns about the efficacy and safety of the drugs by assuring patients about the conclusive nature of the experimental process (Mahant, 2020). Further, the risk of driving patients away from clinical trials undermine the relevance of experimental drugs in responding to the needs and expectations of terminally ill patients. The emphasis on trial population jeopardizes the need to ensure that more people benefit from the intervention.

Conclusion

Generating new knowledge about diseases and developing new drugs and treatments create opportunities for terminally ill patients to reduce morbidity and mortality risks. The rigorous study and evidence to ascertain the safety and efficacy of new drugs provide insights into the safety of experimental interventions. However, healthcare providers should consider the principles of beneficence, autonomy, justice, and informed consent to ascertain the safety and effectiveness of experimental drugs and treatments in reducing morbidity and mortality risks.

References

Edlin, M. (2018). Right to try pros and cons. Medical Economics, 28(6), 1-68. https://www.managedhealthcareexecutive.com/view/aduhelm-great-expectations-fizzle